Switching Medications From Intravenous to Oral

CompletedOBSERVATIONAL
Enrollment

921

Participants

Timeline

Start Date

May 1, 2019

Primary Completion Date

August 31, 2019

Study Completion Date

August 31, 2019

Conditions
Physician's RoleAdministration, Oral
Interventions
OTHER

Clinical Decision Support prompted to the clinician to convert drug.

This study is designed to further research the conversion of Intravenous medications to oral medications in patients in an inpatient setting whenever it is appropriate and safe. We have chosen eight medications to research in this study. These medications were chosen because large difference in cost between an intravenous (IV) dose of this medication versus an oral (PO) dose of this medication exist. This study aims to further evaluate the appropriateness and safety of converting IV medications to PO medications for hospitalized patients through a pilot clinical trial.

Trial Locations (1)

37203

Vanderbilt University Medical Center, Nashville

All Listed Sponsors
lead

Vanderbilt University Medical Center

OTHER

NCT03666520 - Switching Medications From Intravenous to Oral | Biotech Hunter | Biotech Hunter